![louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026](https://www.torhoermanlaw.com/wp-content/uploads/2026/02/Trulicity-Lawsuit-Severe-Gastrointestinal-Issues-Alleged-in-GLP-1-Lawsuits.jpg)
louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026
Description
84, 556560 [DOI] [PubMed] [Google Scholar] 39
![louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026](https://www.wisnerbaum.com/wp-content/uploads/practice-area-featured-img-ozempic.webp)
doi:10.1016/j.metabol.2015.09.011 82
![louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026](https://framerusercontent.com/images/sBK5QUDeTfHolCznnIdM12SQjs.png?width=3000&height=3000)
While this risk has not been confirmed in human epidemiological studies, patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use orforglipron or any GLP-1 receptor agonist
![louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026](https://www.atraxialaw.com/uploads/glps-legal-events.jpg?w=500)
It is important not to take a second dose just because you dont feel immediate relief
![louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026](https://lundyllp.com/wp-content/uploads/2023/12/Ozempic-Wegovy-Mounjary-gastrointestinal-injuries-claims-Louisiana-Lundy-LLP.jpg)
In 2025 so far, the FDA has received 379 reports of ischemic optic neuropathy associated with Ozempic, Wegovy, and semaglutide combined
![louisiana glp-1 ileus lawsuit Trulicity [2026] Ozempic Lawsuit Update May 2026](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1364380202382898)
